Aim: To describe the clinical spectrum of achiasmia, a congenital disorder of reduced relative decussation at the optic chiasm. Methods: A retrospective case note and patient review of nine children (four boys). Achiasmia was defined by the combination of a characteristic asymmetry of the monocular visual evoked potential (VEP) response to flash and neuroimaging showing reduced chiasmal size. Results: Three of the children had an associated skull base encephalocele with agenesis of the corpus callosum. In two patients achiasmia was associated with septo-optic dysplasia. Three patients had no neuroimaging abnormalities other than reduced chiasmal size and have no known pituitary dysfunction. One child had multiple physical deformities but the only brain imaging abnormality was reduced chiasmal size. Conclusions: Some children with disorders of midline central nervous system development, including septo-optic dysplasia and skull base encephaloceles, have congenitally reduced chiasmal decussation. Reduced relative decussation may co-exist with overall chiasmal hypoplasia. Children with an apparently isolated chiasmal decussation deficit may have other subtle neurological findings, but our clinical impression is that most of these children function well.
T he optic chiasm, shaped liked the letter X, is named after the Greek letter chi (x). Decussation of retinal fibres at the chiasm appears to be the evolutionary ''default pathway'' and the amount of ipsilateral projection correlates with binocular specialisation. 1 2 Clinically, most cases are due to acquired abnormalities caused by compression, trauma, or inflammation. In some individuals, decussation of retinal ganglion cell axons at the chiasm is selectively reduced during development. 3 4 Abnormal decussation could be the result of disruption in molecular mechanisms that guide midline axonal crossing. This is an area of active molecular genetic research. Signalling pathways have been identified that produce an achiasmic phenotype-for instance, retinal axons do not decussate in Pax-2 deficient mice, entering the ipsilateral optic tract instead. 5 6 When Pax-2 is blocked, Sonic hedgehog expression at the ventral midline is prolonged. 7 Other molecular pathways implicated in midline attraction or avoidance of retinal ganglion cell axons include CD44 (a surface bound adhesion molecule), 8 Zic2 (a zinc finger transcription factor), 2 and the Ephrins. [9] [10] [11] An alternative to the molecular genetic paradigm is a vascular disruption sequence; during embryogenesis branches of the anterior cerebral artery supply the chiasm, anterior hypothalamus, and septum pellucidum. 12 In humans, chiasmal decussation of nerve fibres and development of the contralateral optic radiation has been reported despite unilateral optic nerve aplasia. 13 Abnormalities of decussation can be revealed by hemispheric asymmetry of monocular visual evoked potentials (VEP). 4 14 In humans, both reduced (in achiasmia) 15 16 and excess (in albinism) 17 decussation correlate with nystagmus. However, a VEP asymmetry does not necessarily predict readily visible nystagmus-as shown in albinism. 14 18 Significant asymmetry of the monocular VEP response is not always found in albinism with nystagmus. 19 20 Complete absence of the chiasm (chiasmal aplasia) may not be associated with other significant CNS abnormalities: a girl with bilateral microphthalmos, bilateral aplasia of the optic nerves, chiasm and tracts had no other apparent abnormalities and was developing normally up to the age of 3.5 years. 21 Also, aplasia of the chiasm was associated only with optic nerve hypoplasia and polymicrogyria. 22 The term ''non-decussating retinal fugal fibre syndrome'' (NDRFFS) has been used to describe isolated absence of chiasmal crossing. 23 There is an animal model-a strain of Belgian sheep dogs with absent chiasmal decussation and the combination of horizontal and seesaw nystagmus. 24 The clinical features of NDRFFS are combined horizontal and seesaw nystagmus, an achiasmic VEP pattern, absence of endocrine abnormalities, normal visual fields, and normal foveal reflexes. 15 23 To our knowledge, the state of their optic discs on ophthalmoscopy has not been photographically detailed in the literature 3 15 23 25-27 but is described as normal. [25] [26] [27] Head ''shudder'' or ''tremor'', torticollis, and alternating esotropia have been reported in at least three of four reported patients with the combined horizontal and seesaw nystagmus of NDRFFS. 15 26 Nystagmus in patients with a range of chiasmal disorders may be classically ''seesaw'', but nystagmus is not necessarily present and may be of many less specific types.
There are other cases in which reduced chiasmal decussation does not fall within the strict criteria of NDRFFS. A retrospective case note and patient review was undertaken to define better the clinical spectrum of achiasmia.
METHODS

Patient selection
From the records of the Great Ormond Street Hospital (GOSH) Ophthalmology Department, nine children (four boys) aged 4-14 years were identified with a diagnosis of achiasmia. All of these children had previously been clinically examined and had undergone clinically appropriate neuroimaging and VEP studies. One patient had died before the start of this study, three were re-examined at routine follow up visits to GOSH, one (who had been previously evaluated at GOSH) was reviewed locally by a paediatric ophthalmologist, and four were reviewed specially at GOSH. Inclusion criteria were presence of nystagmus, VEP documentation of consistent positive contralateral crossed asymmetry to flash, 16 and reduced chiasmal size on neuroimaging. Where appropriate, VEPs and eye movement studies were repeated.
Data on ocular motility, strabismus, refraction, and visual acuity were recorded and the anterior segment and fundi were examined in all cases. Whenever possible, eye movements, fundus photographs, and formal visual fields were recorded. All previous hospital notes were reviewed.
The study was approved by the Great Ormond Street Hospital and the Institute of Child Health (University College London) research ethics committee Electrophysiology VEPs to flash 16 were recorded from three occipital electrodes-one placed 2-3 cm above the inion and two placed midway between the inion and mastoid process. Simultaneously, flash electroretinograms were recorded from skin electrodes placed along the inferior eyelid margin.
Eye movement recording
Quantitative measurements of eye movements were made with an infrared limbus tracking system (Skalar Medical, Delft, The Netherlands). Horizontal movements were recorded from the right eye and vertical movements were recorded from the left eye. A chin rest was used to stabilise the head and the subject was asked to fixate on a red LED light subtending a quarter of a degree of visual angle. The eye movement recordings were calibrated by asking the subjects to fixate additional positions spaced ¡15 degrees apart horizontally and ¡5 degrees apart vertically. Video recordings of eye movements were also made to facilitate interpretation of the quantitative eye movement recordings.
Neuroimaging
All previous brain neuroimaging results were reviewed to confirm reduced chiasmal size and to review other associated brain deformities.
RESULTS
The case records and clinical examination results of the nine children are shown in table 1. The appearance of the optic nerves and relevant neuroimaging is shown in figs 1-9: fundus photographs were not available for cases 2 and 4 and only one fundus was available for case 9. All patients had a characteristic pattern of monocular VEP asymmetry to a flash of light (the VEPs for case 1 are shown in fig 1I and for case 6 in fig 6G) . 16 Three of the children had a skull base encepahalocele and agenesis of the corpus callosum (cases 6, 7 and 8). In two patients achiasmia was associated with septo-optic dysplasia, a combination of absent septum pellucidum, optic nerve hypoplasia, and hypopituitarism 12 (cases 4 and 5). Three children had no neuroimaging abnormalities other than reduced chiasmal size and have no known pituitary dysfunction (cases 1, 2 and 3); however, one had mild Asperger syndrome and one had subclinical epileptiform seizure activity. One child had multiple deformities including microtia, hemifacial microsomia, oesophageal atresia, and hydronephrosis; the only brain imaging abnormality was reduced chiasmal size (case 9).
Corrected acuities varied widely: one eye had 0.1 LogMAR, the others between perception of light and 0.5, 10 eyes had between 0.5 and 0.6. Eight patients had a best corrected binocular acuity of at least 0.6 LogMAR (table 1). All children had normal colour vision as tested with Ishihara colour plates. Stereo acuity as tested with Titmus fly and/or TNO stereo acuity tests was recorded as absent in all patients. No specific pattern of nystagmus was common to the study patients. The sample includes pure horizontal, rotary, and compound rotary or circumrotary and horizontal nystagmus (table 1) . Further details can be seen on the video available on the journal website (http://bjo.bmjjournals.com/supplemental)
Our patients seem mostly to fall into three subtypes: type A (three patients) with isolated achiasmia on neuroimaging, Head shake XT = exotropia; ET = esotropia. *Type: A = no other midline abnormality on imaging except small chiasm; B = septo-optic dysplasia (optic nerve hypoplasia, hypopituitarism, deficient septum pellucidum); C = skull base encephalocele + agenesis of the corpus callosum + hypopituitarism.
ÀAngle of strabismus in prism dioptres.
type B (two patients) with septo-optic dysplasia, and type C (three patients) with skull base encephalocele and agenesis of the corpus callosum (table 1) . One patient (case 9) did not fit into any of these groups.
DISCUSSION
Definition and classification of achiasmia
There is probably some chiasmal hypoplasia whenever there is optic nerve hypoplasia. In most of these cases, normal proportions of retinal ganglion cell axons have been directed ipsilaterally and contralaterally but, overall, are fewer in number. The optic chiasm in achiasmia is not just hypoplastic but it has the essential absence or relative lack of crossing fibres; thus, optic nerve hypoplasia and achiasmia may coexist (figs 5A and B, 6A and B, 7B). The term ''achiasmia'' may strictly suggest an absence of the chiasm but, for clarity, it is used here to identify the essential abnormality of crossing fibres. Complete absence of the chiasmal structure, often associated with optic nerve aplasia, is thus not achiasmia; the term ''chiasmal aplasia'' is more appropriate. 21 22 The definition of achiasmia is therefore not as strict as NDRFFS (defined above). The criteria for diagnosis are positive contralateral asymmetry of the monocular VEP response to flash (figs 1I and 6G) and neuroimaging showing reduced chiasmal size (figs 1G, 2, 3A and B, 4, 5C, 6E, 8D, and 9B). Although nystagmus was part of the inclusion criteria for this study, it may not be a constant feature of achiasmia-just as the excess decussation in albinism is not inevitably associated with clinical nystagmus. 18 To our knowledge, four patients (all female) have been reported with NDRFFS. 15 23 26 A fifth female has been described with isolated achiasmia but she only has horizontal nystagmus. 25 The male:female ratio in our mixed group of patients with achiasmia is 4:5. One of three patients with isolated chiasmal deficit (our type A) is male (case 1). Another (case 9) who had an isolated small chiasm on neuroimaging but other associated facial and visceral problems is also male.
From our small sample and those in the literature, some general patterns appear to emerge. While the numbers of patients with this rare finding are small, we feel that there may be three main groups of patients with achiasmia: N Type A: reduced decussation with optic nerves of normal appearance on clinical examination. 25 26 A small chiasm may be the only abnormality on the brain MRI scan. This group appears to overlap with NDRFFS. There may be seesaw 23 or purely horizontal 25 nystagmus, and the visual fields appear to be normal. 23 In our patients, cases 1 and 3 had normal formal visual fields, case 2 (who was 4 years old) had behaviourally normal fields. Abnormal head posture, strabismus, 26 and other subtle neurological abnormalities (mild autism in case 1 and subclinical epileptiform temporal lobe activity in case 2) may be present.
N Type B: reduced decussation in combination with chiasmal hypoplasia and the midline defects of septo-optic dysplasia, 16 28 a combination of absent septum pellucidum, optic nerve hypoplasia, and hypopituitarism (cases 4 and 5).
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N Type C: reduced decussation and chiasmal hypoplasia in association with clefting disorders and encephaloceles of the skull base (cases 6, 7, and 8). Agenesis of the corpus callosum was present in all three of our patients with basal encephaloceles. The association of corpus callosum agenesis, morning glory disc, and optic nerve staphylomas with skull base encephaloceles has been previously reviewed. 29 One patient in our series (case 9) did not fit into any of the above categories. This child suffered from multiple facial (microtia, hemifacial microsomia), visceral (oesophageal atresia, hydronephrosis), and developmental problems in addition to an isolated small chiasm; the MRI scan was otherwise normal.
Visual fields in achiasmia
Congenitally reduced chiasmal decussation need not be associated with visual field defects. The visual field may be On examination the left optic nerve was smaller than the right. Coronal T1 weighted images through the chiasmatic recess reveal the chiasm to be small and pulled down (arrow). The septum pellucidum is absent (arrowheads). Fundus photography was impossible due to lack of patient cooperation and nystagmus.
abnormal due to optic nerve hypoplasia (case 6, fig 2) but does not necessarily have a bitemporal hemianopia pattern such as that seen with traumatic shearing of the chiasm. [30] [31] [32] In cases 1 and 3 the appearance of the optic nerves and formal visual field testing were normal (figs 1C and D, 3E and F) The finding of normal visual fields in association with an isolated small chiasm on neuroimaging has been reported previously. 15 23 27 A full visual field is consistent with studies of the lateral geniculate body (LGN) in the canine model of isolated achiasmia: misdirected nasal fibres form ipsilateral mirror image maps in those LGN layers that normally would have received nasal fibres from the contralateral eye. 33 The optic discs may appear normal in achiasmia. [25] [26] [27] The size of the optic nerves, density of axons, and total number of axons do not differ between achiasmic mutant and normal dogs, but the area centralis of the achiasmic dogs is smaller and has a lower peak ganglion cell density than that of normal dogs. 34 Seesaw nystagmus and achiasmia Seesaw nystagmus was described by Maddox in 1914 . 35 There is a conjugate torsional component and a dysconjugate vertical component. Both eyes rotate clockwise and then counterclockwise. The intorting eye rises while the extorting eye falls. However, the definition of seesaw nystagmus has not remained strict over time. In 1946 Rucker 36 described seesaw nystagmus in a patient with vertical and torsional movements in the left eye (as described by Maddox), but only vertical movement in the right eye. Jensen described seesaw nystagmus as a ''rare disjunctive form of vertical nystagmus in which the eyes perform opposed vertical movements'', but did not specify a necessary torsional component. 37 Disorders of the mesencephalon, [38] [39] [40] chiasmal trauma, 30 31 and chiasmal compressive lesions 41 42 are associated with seesaw nystagmus. Achiasmia is a recent addition to the differential diagnosis of seesaw nystagmus. 43 In initial reports the pattern of nystagmus in achiasmia was limited to the combination of congenital horizontal and seesaw nystagmus. 43 44 However, purely horizontal nystagmus may be present in achiasmia, as illustrated by cases 1, 2 and 9 in this study and in a previous case report. 25 Combined horizontal and torsional nystagmus also appears to be consistent with achiasmia as illustrated by cases 4 and 7.
Conclusions and general observations
Certainty of the diagnosis of achiasmia can only be achieved by a combination of MRI scanning and VEPs. A number of our original sample of patients with VEP features of contralateral crossed positivity had to be excluded because the study was too noisy and/or was not reproducible on subsequent testing. It is also not possible to determine if there is complete absence of decussation on the MRI scan; this would require extremely thin sections.
Despite the wide spectrum of midline congenital CNS malformations in our achiasmic patients, most function well; five of the nine patients attend mainstream schools and are not behind their age matched peers. One (case 1) participates in junior golf competitions; another (case 6) performs well in arts and crafts. Other reports corroborate our finding of a high level of functioning in these children. 15 26 27 Full visual fields 3 23 27 44 and ophthalmoscopically normal optic discs [25] [26] [27] are consistent with achiasmia, as shown by our cases 1 and 3. There does not appear to be any single pattern to the nystagmus: it may be rotary, seesaw, or purely horizontal. Subtle neurological problems may co-exist with ''isolated'' forms, as reported elsewhere 15 26 and in our cases 1 and 2.
Achiasmia appears to be rare, but a portion of children diagnosed with ''idiopathic congenital motor nystagmus'' may have reduced decussation as part of the underlying abnormality-especially since VEPs and MRI scans are often not performed when the appearance of the nystagmus is ''classic''.
Relatively reduced decussation affects a subset of children with developmental abnormalities that include midline facial defects, basal encephaloceles, midbrain defects, pituitary and hypothalamic defects, alone or in combination. Whenever there is reason to suspect congenital chiasmal maldevelopment, VEPs, MRI scans, endocrine assessment, and visual follow up until mature are recommended.
chiasmal decussation
The achiasmia spectrum: congenitally reduced 
Primary nasolacrimal duct malignant mucosal melanoma
Primary nasolacrimal duct malignacy is rare. Only a few tumours have been reported originating from this location including lymphoma, 1 Kaposi's sarcoma, 2 adenocarcinoma, 3 angiofibroma, 4 and squamous cell carcinoma. 5 Mucosal melanoma represents 1-2% of all melanomas, 6 with 25-50% in the head and neck-that is, upper respiratory tract, oral cavity, and pharynx. Other sites include urinary, female genital, and ano-rectal tracts. These tumours are uncommon, present in the fifth to eighth decades, have slight male preponderance and are more common in darker skinned individuals. Cutaneous melanoma presents two decades earlier and is more common in white people and is associated with sun exposure.
Case report
A 41 year old Asian male presented to the oculoplastic service with a 3 month history of right sided intermittent bloody tears and epistaxis. He described right simple epiphora for at least 2 years treated with a three snip procedure. Probing the right nasolacrimal system confirmed normal canaliculi and easy entry of the probe into the lacrimal sac. Irrigation demonstrated complete nasolacrimal duct block and reflux of dark bloody tears. Nasal endoscopy (rigid Hopkins nasal endoscope) revealed a greyish mass emerging from the lower end of the nasolacrimal duct into the inferior meatus ( fig 1) .
Magnetic resonance imaging (MRI) and computed tomography (CT) scans (fig 2)
demonstrated dilation of the entire length of the nasolacrimal bony canal with a soft tissue mass occupying the lumen of the nasolacrimal duct. The mass was invading the osteomeatal complex, extending into the anterior ethmoidal sinus, causing obstruction to drainage of both maxillary and frontal sinuses.
A transnasal incisional biopsy of the inferior meatus lesion was performed under local anaesthetic. Histopathological analysis of the biopsy showed sheets of epithelioid cells with prominent nucleoli and vesicular cells on a routine haematoxylin and eosin stain ( fig 3) . Although the lesion was pale, pigment was visible on the haematoxylin and eosin stain, suggestive of melanoma. Immunohistochemical studies were positive for immunological markers HMB45 and S-100 protein, confirming a diagnosis of melanoma.
No regional lymphadenopathy was present and PET (positron emission tomography) scan excluded the presence of metastases.
Wide local cranio-facial-orbital resection of the tumour was performed, via a lateral rhinotomy approach (fig 4) . The nasolacrimal duct, part of the lateral wall of the nose, the lacrimal sac, distal upper and lower canaliculi, and inferomedial orbital fat were excised. Tumour extended into the maxilla but not into the lacrimal sac. Peroperative frozen sections from the excision margins, including orbital fat, demonstrated clearance of tumour. This allowed preservation of the eye.
Adjunctive therapy was given to limit local recurrence and distant spread. The patient received 20 sessions of radiotherapy (50 Gy) to the right maxillary antrum, and also immunological therapy (vaccination with autologous dendritic cells pulsed with allogenic tumour lysate, and whole body hyperthermia accompanied by low dose interferon).
Three years after presentation there was no local recurrence of tumour. Unfortunately, the patient developed bone pain and CT scan revealed metastatic spread to the right acetabulum and T8, T9, and T11 vertebrae with localised spinal cord compression. He underwent radiotherapy to the right acetabulum and spine. The patient died approximately 6 months later.
Comment
Nasolacrimal duct primary mucosal melanoma is previously unreported. The closest relations are lacrimal sac melanoma (5% of lacrimal sac tumours) 7 8 and sinonasal mucosal melanoma (5% of all sinonasal malignacy). 6 9 Lacrimal sac melanoma can present with epiphora, bloody tears, and epistaxis. Sinonasal melanoma can present with nasal obstruction and epistaxis. Orbital extension causes proptosis and diplopia. Both lacrimal sac melanoma and sinonasal melanoma are insidious in onset with poor visibility leading to late presentation.
Standard treatment of primary sinonasal melanoma is radical wide local surgical excision. Local recurrence can occur and the very vascular nature of mucosal tissue makes regional and distant metastases common, often accompanying late presentation. Postsurgical radiotherapy may prevent local recurrence, but is unlikely to prevent distant metastases. 10 Other adjunctive treatments are not clinically proved to be beneficial. Chemotherapy has no positive effect, and newer immunological treatments are still under investigation. Sinonasal mucosal melanoma has a high mortality rate, with 5 year survival between 10-50%. 6 Lacrimal sac melanoma has a similar prognosis. 7 8 This case demonstrates the importance of thorough clinical examination (including nasal endoscopy) and imaging in patients presenting with epiphora, bloody tears, and/ or epistaxis. Delay in detection and treatment may be fatal.
Glycosylation type Ic disorder: idiopathic intracranial hypertension and retinal degeneration
We report a young woman with type Ic congenital disorder of glycosylation (CDG) with new clinical features of idiopathic intracranial hypertension, retinal degeneration, and novel mutations of ALG6. Patients with known or suspected CDG should receive a full ophthalmic examination including dilated fundus examination and electroretinography. CDG is a rare group of autosomal recessive metabolic disorders. The two major subgroups are type I, caused by dysfunction of glycosylated protein assembly, and type II, caused by abnormal processing of glycosylated protein end products after assembly. 
Case report
Our patient, with non-consanguineous parents, was noted at birth to have incomplete digits on her hands and feet. She had episodes of apnoea early in life and the onset of seizures at age 20 months. Delayed physical and developmental milestones were evident early. Levels of follicle stimulating hormone and luteinising hormone were low and a diagnosis of polycystic ovarian disease was made. She underwent esotropia surgery at age 4 years and at 19 years developed thrombosis of the superficial femoral vein. Coagulation factor studies revealed very low factor XI levels. Isoelectric focusing of serum transferrin was suggestive of a congenital disorder of glycosylation. Sequencing of the ALG6 gene showed a novel three base deletion (897-899 delATT) and an intronic splice site mutation (IVS7+2T.G). 2 The patient was obese without signs of abnormal fat distribution. She blinked to light and no strabismus was identified by corneal light reflex. Further ocular examination was not feasible. On examination under anaesthesia at age 20 years, the anterior segment was normal. Dilated ophthalmoscopy showed bilateral optic nerve pallor with elevation of each nerve, diffuse retinal pigment epithelial granularity most notable in the macula, and attenuated retinal vessels (fig 1) .
Electroretinography revealed prolonged implicit times on scotopic and photopic functions. Because of the elevated optic nerve heads, head magnetic resonance imaging was performed and was normal; lumbar puncture revealed an elevated opening pressure of 350 mm H 2 O (nl 70-180 mm H 2 O), a glucose of 50 mg/dl (nl 50-75 mg/dl), and a protein of 44 mg/dl (nl 15-45 mg/dl) without white blood cells. A diagnosis of idiopathic intracranial hypertension was made.
Comment
Isoelectric focusing of serum transferrin is the most common screening technique for types I and II CDG. 1 Many congenital disorders of glycosylation have been identified based on mutational and enzyme analyses. Type I congenital disorders of glycosylation are caused by reduced functions of the genes for the assembly and processing pathways of N-glycosylation; a decrease in anodal fractions and an increase of disialotransferrin and asialotransferrin are suggestive of the diagnosis.
Ophthalmic features of the most common congenital disorder of glycosylation, type Ia (OMIM #2I2065) include myopia, attenuated retinal vessels, bone spicules, esotropia, and nyctalopia 3 ; this disease subtype is caused by a deficiency of phosphomanomutase (OMIM #212065) encoded by phosphomannomutase-2 (PMM2; OMIM *601785) gene. In CDG type Ic, much less common, a homozygous amino acid substitution, A333V substitution, in the gene encoding a1,3-glucosyltransferase is the most common mutation. 4 There is no known biochemical link between CDG and idiopathic intracranial hypertension; the association in our patient may be coincidental. Grunwald and colleagues 5 found strabismus to be present in all eight patients with CDG type Ic; neither idiopathic intracranial hypertension nor retinal abnormalities were reported.
The developmental delay evident in our patient was severe. She possessed simple communication skills limiting her ability to complain of visual changes or symptoms of intracranial hypertention. No specific clinical presentation has been identified for the CDG group of diseases. Failure to thrive, unexplained seizures, hypotonia, and developmental delays are all frequently present.
In conclusion, we report an adult patient with CDG type Ic, confirmed by identification of mutations in the ALG6 gene, and describe new systemic and ocular features including idiopathic intracranial hypertension., optic 
Woodhouse Sakati syndrome associated with bilateral keratoconus
Keratoconus is a non-inflammatory degenerative corneal disease characterised by a localised region of stromal thinning spatially associated with a cone-shaped deformation of the surface. It is most commonly an isolated sporadic condition. 1 Recent reports demonstrate genetic mapping to chromosomes 16q, 21q, and 18p, as well as association of HLA-A26, B40, and DR 9. 2 3 Keratoconus has been reported in clinical contexts with 36 other multisystem disorders. 1 2 We describe the first two cases of keratoconus in association with Woodhouse Sakati syndrome.
Case report
Two sisters (aged 14 years and 18 years) presented with history of bilateral progressive loss of vision over 8 years. Progeny of a first degree consanguineous marriage, they were the only members in the family of six siblings with a diagnosis of Woodhouse Sakati syndrome. Both sisters exhibited variable manifestations of the syndrome including hypogonadism, primary amenorrhoea, hypothyroidism, electrocardiographic abnormalities, and dysmorphic features. The elder sister also had a mild degree of mental retardation. None of their siblings or parents 
Comment
Woodhouse Sakati syndrome (MIM 241080) is an extremely rare genetically determined autosomal recessive disorder. It was first described in two Saudi Arabian families, 4 and later reported in a single Turkish family. Table 1 presents manifestations of the syndrome. 4 5 We report a new association in our two cases. Such concurrence of early keratoconus and the syndrome raises the possibility of a genetic linkage, although a chance association cannot be excluded.
On one hand, either chromosomal rearrangements such as chromosome 7, 11 translocation or genetically determined syndromes such as this syndrome should be considered in cases where keratoconus is present during childhood. 6 That may explain the early presentation of keratoconus in our cases. An additional factor is that keratoconus tends to be more prevalent and diagnosed at a younger age in Asians than in white people. 3 On the other hand, familial keratoconus in our cases cannot be excluded because of the presence of keratoconus in a single relative and parental consanguinity. Positive family history has been reported in 6% to 10% of keratoconus cases and is suggested to be caused by autosomal dominant inheritance with incomplete penetrance. [1] [2] [3] To the best of our knowledge, this is the first report of bilateral keratoconus in association with Woodhouse Sakati syndrome. Ophthalmologists and endocrinologists should be aware that patients with this syndrome who complain of poor vision should be suspected of having keratoconus once other more common conditions are ruled out.
The authors have no interests or disclosures to report. This is an institutional review board (IRB) exempt single case report with no identifiable patient information. Retinal ischaemia in type 1 neurofibromatosis
Systemic occlusive arteriopathy associated with type 1 neurofibromatosis (NF-1) has been well described in the aortic and cerebral vasculature 1 ; however, it is poorly documented in the retinal vasculature with, to our knowledge, only three reported patients whose retinal vasculopathy was diagnosed at a later sequelae stage. [2] [3] [4] We report the case of a young woman with NF-1 who presented with acute macular ischaemia combined with diffuse retinal arterial occlusive disease. One month after the initial examination, all the cottonwool spots disappeared, and sheathing appeared in a few veins. FA showed worsening of the retinal arteriolar occlusions in the mid-periphery (fig 2) . A panretinal photocoagulation was subsequently performed. At 2 year follow up, left visual acuity remained unchanged, and the patient did not exhibit any preretinal fibrovascular proliferation.
Case report
Comment
To our knowledge, only three cases of retinal vascular occlusion in patients with NF-1 have been previously reported. All cases were diagnosed at a later sequelae stage. Moadel et al 2 and Kadoi et al, 3 respectively, reported the cases of a child who presented with an unilateral amblyopia, and a young woman with a history of unilateral poor vision. They both presented with diffuse sheathing of retinal vessels, retinal arteriovenous communications, and avascular peripheral retina with fibroglial proliferation. Thölen et al 4 described a young man whose routine eye examination showed narrowing of a superotemporal retinal arteriole with irregular diameter of the corresponding vein, fibroglial proliferation, and arteriovenous communications. These authors suggested the possibility of either a primary occlusion of a retinal arterial or venous branch or alterations of vessel development. In contrast with other reported cases, our patient presented with acute unilateral occlusion of macular arterioles, combined with diffuse retinal arterial occlusive disease, in adulthood. Panretinal photocoagulation may have prevented fibroglial proliferation which was described in previous reported cases. Recent reports suggest that pathogenesis of NF-1 vasculopathy may result from dysfunction of neurofibromin, the NF-1 gene product, in vessel endothelial and smooth muscle cells. 5 Our case shows that NF-1 related occlusive retinal arteriopathy may suddenly appear during adulthood and should be considered in patients with NF-1 or in young adults with retinal vascular occlusive disease and unknown NF-1.
Are biometric parameters a risk factor for idiopathic macular hole formation? Results of a matched case-control series
Recognised risk factors for the formation of idiopathic full thickness macular holes (IFTMH) include age, female, sex, and high myopia.
1 2 However, we noticed that patients with IFTMH within our population, tended to have shorter than normal axial lengths. An age and sex matched case-control study was therefore performed to test this hypothesis and determine whether biometric factors may be associated with formation of IFTMH.
Methods
Consecutive patients undergoing surgery for IFTMH had age, sex, axial length in millimetres (mm), and corneal keratometry (K) measurements in dioptres (D) recorded.
For each case three age and sex matched controls were randomly identified from a cataract surgery database (Medisoft). Biometric measurements were made in all cases and controls using the IOL-Master (Zeiss, Jena). Mean corneal curvature was calculated by averaging the two K readings.
Descriptive statistics and conditional logistic regression method for analysis of matched pair data were used to infer estimates.
Results
Thirty five consecutive cases and 105 controls were identified with a mean age of 67. Evidence suggests that the longer the axial length the less the odds of being a case; odds ratio (OR) 0.67 (p = 0.036, CI 0.47 to 0.77) and the higher the dioptre power of the curvature the higher the odds of being a case as opposed to a control; OR 1.50 ( p = 0.02, CI 1.07 to 2.01).
Comment
As in previous studies our population sample demonstrates an increased risk of IFTMH in females with most cases clustering in the 60-70 year age group. 3 4 The mean axial length in controls was also found to be similar to results in the published literature. 5 6 Mean spherical equivalence (MSE) was measured by the Eye Disease Case Control Study Group 7 and although their findings were statistically insignificant, their regression analysis found an increased likelihood of hypermetropia in the IFTMH cases. Our cases clustered in a relatively narrow range of axial lengths (21 mm-25.31 mm in the cases compared to 20.64 mm-29.48 mm in the controls) with the maximum axial length in the cases being 25.31 mm (fig 1) . In Japanese literature, high myopia is a prominent, recognised risk factor and in one study the overall mean MSE was 20.66 D. 2 From our study it appears myopic macular holes are encountered much less frequently in a predominantly white population.
We believe the significant corneal dioptric differences found may be a result of the natural process of emmetropisation of a shorter eye, or alternatively be an independent risk factor.
IFTMH are thought to arise from retinal surface traction which in turn arises from an abnormal and incomplete posterior vitreous detachment. 8 Our results suggest that eyes with shorter than average axial lengths and therefore lower volume vitreous cavity are either at increased risk of developing such incomplete and abnormal vitreous detachments or, in the presence of such an incomplete vitreous detachment, of developing a macular hole. We are not aware that shorter axial length has previously been shown to be significantly associated with IFTMH. 
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Case report
A 20 year old woman presented with a 1 week history of bilateral blurred vision, dyspnoea, and dry cough. Visual acuity was reduced to 6/36 bilaterally with posterior subcapsular cataracts. Funduscopy disclosed multifocal, creamy-yellow choroidal lesions at both posterior poles with exudative retinal detachments at the maculae (fig 1) . Optic discs and retinal vessels were normal. Fluorescein angiography showed early patchy hypofluorescence (corresponding to the choroidal lesions) and late hyperfluorescence with pooling beneath the detachments. Three years earlier she had undergone a successful allogeneic bone marrow transplant for chronic myeloid leukaemia. Her maintenance therapy included inhaled pentamidine as prophylaxis against P jiroveci infection. However, she admitted to not taking her inhaled pentamidine. Molecular genetic and radiological investigations excluded leukaemic recurrence. Chest x ray showed left lung shadowing and bronchoalveolar lavage isolated P jiroveci. P jiroveci pneumonia with P jiroveci choroiditis was diagnosed and high dose oral co-trimoxazole 7.2 g/day (120 mg/kg/day) and prednisolone 60 mg/day commenced. Within 2 weeks her respiratory and ocular symptoms improved. Visual acuities returned to 6/9 and the fundal appearances resolved. She was discharged on daily oral co-trimoxazole 960 mg, prednisolone 20 mg, and inhaled pentamidine. Three weeks later she was readmitted with increasing dyspnoea and blurred vision. Chest x ray and computed tomography findings were compatible with diffuse interstitial fibrosis in both lungs. Funduscopy revealed peripapillary choroidal lesions with disc swelling bilaterally (fig 2) . This time the choroidal lesions were peripapillary only rather than throughout the posterior pole, with exudative detachments inferiorly. Recurrent P jiroveci pneumonia and choroiditis was diagnosed and oral atovaqoune and high dose prednisolone were commenced. Within 3 weeks her fundal appearance resolved leaving only some pigmentary changes. Her discharge medication included daily oral prednisolone 40 mg, cotrimoxazole 960 mg, and inhaled pentamidine. There have been no further intraocular recurrences.
Comment
Pneumocystis jiroveci is a commensal, found in the respiratory tract of healthy individuals. It can cause infections of almost any organ in immunocompromised hosts.
1-3 P jiroveci choroiditis has been reported in immunocompromised patients despite prophylactic use of inhaled pentamidine. 4 5 The diagnosis is based on the clinical findings of multifocal yellowish circular choroidal lesions at the posterior pole. P jiroveci has been found in these lesions on histological sections 3 5 and the lesions resolve on systemic anti-pneumocystis treatment. 4 However, most cases of P jiroveci choroiditis are diagnosed histologically post mortem. 3 6 Thus, the acute clinical findings may be more varied than previously described. In our patient, massive exudative retinal detachments were associated with the previously described choroidal lesions. The clinical picture varied on the second presentation, but there was complete and rapid resolution of the signs with anti-pneumocystis therapy. To the best of our knowledge, this is the first report of P jiroveci choroiditis causing exudative retinal detachments. P jiroveci should be considered in the differential diagnosis of susceptible patients, even if the ophthalmological findings are ''atypical. ' Prothrombotic and atherosclerotic risk factors lack significance in NAION patients harbouring mitochondrial DNA mutations
We recently reported that a group of patients with non-arteritic anterior ischaemic optic neuropathy (NAION) had an increased prevalence of potentially pathological mitochondrial DNA (mtDNA) mutations, implying a link between mitochondrial disease and this optic neuropathy. 1 We decided to investigate the association of other risk factors for NAION in these same patients.
Case reports
NAION patients were genotyped for the presence of prothrombotic polymorphisms that have been reported in association with NAION, 2 3 including factor II G20210A prothrombin variant, factor V Leiden G1691A variant, MTHFR C677T and A1298C variants, platelet glycoprotein receptor IIIa (PI A2 ) allele, and apolipoprotein E (4) allele, as described previously.
4-8
These reports included large control groups that were ethnically matched to our NAION patients and that had been queried regarding the presence of atherosclerotic risk factors. Controls older than 50 years were selected for comparison with NAION patients. Table 1 shows that the prevalence rates for prothrombotic variants among NAION patients did not differ from controls. Reported prevalence of diabetes, hypertension, and hyperlipidaemia was relatively high in NAION patients but was also not significantly different from controls.
Comment
The lack of a significant association between NAION patients and controls in relation to thrombophilic genetics markers has been reported before, 9 and the role of these factors remains uncertain. More surprising is the lack of a statistical association with atherosclerotic risk factors. For example, in our group of NAION patients, 68% were diabetic, but this figure did not differ significantly from the prevalence of more than 50% in well matched controls. This observation reflects the high, and rising, frequency of diabetes and other atherosclerotic risk factors in the developing world.
A few qualifications are appropriate. NAION patients were a relatively small group of Middle Eastern Arabs, and it is possible that a larger group would have yielded statistically significant results or that the observations reported here are specific to this genetically homogeneous population. Atherosclerotic risk factors were assessed by individual report from patients and controls, and the actual prevalence of these disorders may be different from that recognised. Finally, other risk factors, such as homocysteine levels, nocturnal hypotension, or environmental factors 10 were not consistently investigated.
Nevertheless, the fact that the occurrence of NAION cannot be easily explained by the presence of prothrombotic or atherosclerotic risk factors shifts focus to the possibility that mitochondrial abnormalities may be important in the development of NAION. Based on these observations, testing for mitochondrial abnormalities may be warranted in NAION patients, especially the ones without a Tear cytokine has a major role in various pathophysiological conditions of the ocular surface. So far, studies on tear cytokines have shown significant progress in providing an understanding of ocular surface diseases. [1] [2] [3] The information that could be acquired from each subject, however, until recently has been severely hampered by limited sample volume and assay sensitivity. More importantly, it has become apparent that the relative balance between various cytokines and combinations of cytokines could be more important than absolute concentrations. Previous studies showed that the composition of basic and reflex tears was different, which made it more difficult to understand the ocular surface disorder correctly or to treat the patients suitably. 4 5 Cytometric bead array (CBA) is a microparticle based flow cytometric assay that allows us to quantify multiple molecules from a very small sample. 3 6 7 Using this method, we evaluated the inflammatory cytokines of basal and reflex tears from a single sample of individual eyes.
Methods
Twenty three normal volunteers (11 males and 12 females, 22-44 years of age, average 28 years) were recruited for this study. None of the subjects had signs of ocular diseases. The study was performed with the approval of the institutional review board. The basal tear samples of 10-15 ml were obtained from each eye by capillary flow, with no nasal stimulation or previous instillation of drugs or vital dyes. Each sample was collected at 5 pm. No anaesthetic drops were instilled. The samples were collected non-traumatically from the inferior meniscus. Successively, reflex tear samples were collected by inserting application sticks into a participant's nose. The amounts of six inflammatory molecules interleukin (IL)-1b, IL-6, IL-8, IL-10, IL-12p70, and tumour necrosis factor a (TNF-a), were measured by CBA (BD Biosciences, San Diego, CA, USA), according to the manufacturer's instructions. Briefly, for the tear sample and cytokine standard mixture, 10 ml of sample or standard were added to 40 ml sterile purified water, a mixture of 50 ml each of capture Ab-bead reagent and detector Ab-phycoerythrin (PE) reagent. The mixture was subsequently incubated for 3 hours at room temperature, and washed to remove any unbound detector Ab-PE reagent before data acquisition using flow cytometry. A two colour flow cytometric analysis was performed using a FACScan flow cytometer (Beckton Dickinson Immunocytometry Systems). Data were acquired and analysed using BD cytometric bead array software.
Results
The concentrations of IL-1b, IL-6, IL-10, IL12p70, and TNF-a were not significantly different between basal and reflex tears. In contrast, the concentration of IL-8 was significantly decreased in reflex tears compared with basal tears in each eye (paired t test, p,0.01, fig 1) . In order to illuminate the inter-relation of each cytokine, the ratio of two different cytokines is shown in table 1.
Comment
Previously published studies have demonstrated that CBA correlates well with enzyme linked immunosorbent assay (ELISA), but the absolute concentrations obtained from each assay were differed for kits of different manufacturers. 7 Indeed, the concentrations of tear cytokines in the present results were almost equal to the previous report using the same kit. 3 Nakamura et al performed ELISA for multiple cytokines measuring pooled tears. 1 The pooled tears enable measurement of multiple cytokines; however the results can be strongly influenced by samples with high concentrations. Because the absolute concentrations of tear cytokines varied widely, this can have a strong bias. In this study, to our knowledge, we measured the multiple cytokines of basal and reflex tears from a single sample for the first time, which can provide concentration ranges for these cytokines in normal subjects that may prove important for studies of ocular inflammation. Of note, only the concentration of IL-8 was decreased more significantly in reflex tears than in basal tears. Maitchouk et al showed that there is no distinctive role of major and accessory glands in secreting basal or reflex tears, thus these tears might be produced primarily by the same tissue and differences might be only the result of the secretory rate of reflex tears. 8 It was reported that a neuropeptide released from corneal sensory nerves stimulated conjunctival epithelium to secrete IL-8. 9 Because sensory nerves are present in the cornea so abundantly, IL-8 can be produced constantly on the ocular surface. IL-8 is a potent pro-inflammatory cytokine, and has a pivotal role in the host defence system. 10 But excessive IL-8 might be so harmful that constant washout might be helpful for homeostasis of the ocular surface. Indeed, a large amount of IL-8 was found in the tears of dry eyes. 11 Thus, basal tears might be composed of products of the ocular surface including IL-8 and small amounts of reflex tears that are induced by mild stimulation such as blinks.
In summary, the present study showed that pro-inflammatory and anti-inflammatory cytokines/chemokines are present in the ocular surface even in the absence of inflammation and this was detectable from a small sample of single eyes. Stimulating tears, with the exception of IL-8, has minimal effect on cytokine concentration. We believe the CBA technique can make a valuable contribution in understanding the specific immunopathological mechanisms underlying cytokine interaction with the ocular surface. Outcome of implementing the national services framework guidelines for diabetic retinopathy screening: results of an audit in a primary care trust
Systematic screening for diabetic retinopathy is the key to achieving the targets set out in the recently published national service framework (NSF) guidelines. 1 2 One of the two priorities and planning framework (PPF) targets is that by March 2006 a minimum of 80% of people with diabetes are to be offered screening, rising to 100% by December 2007. 3 4 Digital photography is the modality for screening. [5] [6] [7] [8] The British Diabetic Association has established standards for any diabetic retinopathy screening programme of at least 80% sensitivity and 95% specificity.
Screening programme
Our screening programme was set up to evaluate the existing nationally recommended diabetic retinopathy screening service.
In all, 2165 patients were invited over a period of 12 months; 909 participated. At the screening mydriatric drops (1% tropicamide and 2.5% phenylephrine) were instilled. The patients were photographed with a Topcon fundus camera and each photograph was screened and graded by consultant ophthalmologists (table 1) .
Of the total 909; there were 198 patients with retinopathy (grades R1, M, R2, and R3), 644 patients without retinopathy (grade 0), 63 patients with OL (other lesions), and one was (grade U) ungradeable (tables 2 and 3). The sensitivity was 98% and specificity 97%. The retinopathy present was 21% and the referral rate for retinopathy (STDR) was 7%; 59% did not take up the offer to be screened. Some of the reasons cited: 956 (44%) declined or did not respond, 251 (11%) are being screened elsewhere, 11 (0.5%) are not diabetic, five (0.18%) are dead, six (0.27%) are registered blind, and 21 (1%) have moved.
Comment
Our screening methods surpassed the standards set by the NICE guidelines. However 59% of patients did not take up the offer. The achievable standard to which strategic health authorities and primary care trusts are working is 90% uptake of those offered screening with the minimum standards of 70%-80%, but even though quality assurance systems are in place uptake is still very poor.
In the intercollegiate audit, led by the Royal College of Ophthalmologists, data were analysed from 9827 patients with diabetes from 129 general practices in 25 health authorities. The lowest level of coverage in a district was 38% and the highest 85%. In general practice the coverage ranged from 14% to 97%. The likelihood of having an eye examination was marginally higher in districts with a systematic examination rather than opportunistic or without recognised schemes at all.
In the Hounslow Primary Care Trust our hospital episode statistics (HES) are the only existing screening programme. Patients registered with a GP are referred to the HES for the screening. The reasons for the 44% who did not respond were that some did not have the time, some were elderly living on their own with nobody to take them, some did not understand the screening leaflet, and some just forgot.
Problems about coverage could be tackled if we had a central electronic database linked to all screening programmes. Although software providers have been agreed for such a data collection exercise, primary care trusts have yet to implement this. People unable to attend during the week could be accommodated in weekend or evening clinics. These clinics could also be reserved, with bilingual support workers to explain the importance of screening for the ethnic patients. Community networks like the rotary, patient groups, ethnic resource centres, and senior citizens groups can be used. The National Service Framework targets will be achieved only if the diabetic population is convinced of the importance of screening. Table 2 Outcome by grade 
M J Saldanha, U Meyer-Bothling
Grade Sex Total O M 363 F 261 T 624 R1 M 74 F 5 4 T 128 M M 2 3 F 2 1 T 4 4 R2 M 17 F 9 T 2 6 R3 M 1 F 0 T 1 OL M 33 F 3 0 T 6 3 U M 0 F 1 T 1
Case report
A 23 year old Asian man was in his usual excellent general and ocular health until October 2000, when he was struck by a car while walking across the street. He was taken to a local hospital where he was found to have extensive injuries, including bilateral subdural and epidural haematomas. He also had evidence of increased intracranial pressure and required an emergency cranial decompression. Postoperatively, he was evaluated by a neuro-ophthalmologist who noted that the patient's only ocular disturbance was a mild left trochlear nerve paresis. The paresis resolved within about 3 weeks. About 6 months after the injury, the patient developed severe headaches and double vision. He was evaluated by the same neuro-ophthalmologist who had evaluated him previously. He noted that the patient now had a severe dorsal midbrain syndrome characterised by lack of elevation of either eye above the midline associated with an exotropia of 25-30 prism dioptres at distance and near, and a left hypotropia of 5 prism dioptres. An evaluation that included neuroimaging and measurement of intracranial pressure revealed hydrocephalus, and the patient underwent placement of a ventriculoperitoneal shunt with normalisation of intracranial pressure, resolution of neuroimaging evidence of hydrocephalus, and resolution of headaches but without any change in ocular motility or alignment. He was eventually referred to the neuro-ophthalmology unit of the Wilmer Eye Institute at the Johns Hopkins Hospital for evaluation and management.
The patient was examined by me for the first time in September 2001, 11 months after the original injury and about 5 months after he had first been noted to have a dorsal midbrain syndrome. At that time, the examination revealed visual acuity of 20/20 in both eyes at distance and near. Automated perimetry revealed bilateral, incomplete, congruous, superior homonymous quadrantic field defects. Pupils were normally reactive to both light and near stimulation. In primary position, the patient had a 25 prism dioptre exotropia that increased to 35 prism dioptres on attempted right gaze and decreased to 15 prism dioptres on attempted left gaze. There was also a 5 prism dioptre left hypotropia. Both eyes could elevate just barely to the midline. There was no difference in degree of elevation with pursuit versus saccades, and elevation did not improve with the oculocephalic manoeuvre. Lateral gaze and downgaze were normal bilaterally for both pursuit and saccadic eye movements. I recommended consideration of strabismus surgery and asked the patient to return in 4 months for reassessment. He did so in January 2002, at which time his ocular motility and alignment were stable. Specifically, neither eye was able to elevate above the midline, either voluntarily or by the oculocephalic manoeuvre.
In May 2002, I performed a left lateral rectus muscle recession of 7.5 mm and a left medial rectus resection of 6.5 mm with superior transposition of both the lateral and medial rectus muscles one muscle width. Postoperatively, the patient had excellent horizontal alignment, although he still had a small left hypotropia of about 5 prism dioptres and was still unable to elevate either eye above the midline.
I subsequently followed the patient at regular intervals. When I examined him in April 2004, he had no change in his ocular motility or alignment, and I recommended that he consider obtaining a small vertical prism to try to eliminate his residual vertical diplopia. I also recommended that he return in 1 year for reassessment. He did so in August 2005.
When I examined the patient in August 2005, he indicated that he thought his vision had improved. He stated that although he was aware of some double vision, it was somewhat less than it had been previously. He also thought his eyes were ''moving better.'' On examination, the patient's visual acuity with correction was 20/15 in each eye at distance and J1 in each eye at near. Colour vision testing using Hardy-Rand-Rittler pseudoisochromatic plates was 10/10 bilaterally. Visual fields were performed by static technique and showed stable bilateral, incomplete, congruous, superior homonymous quadrantic defects, consistent with damage to both inferior occipital lobes. Pupils were isocoric and normally reactive to light and near stimulation. The patient had full abduction, adduction, and infraduction of both eyes. In addition, he now was able to elevate both eyes about 35˚above the midline. He had normal velocity saccades in all directions, but he developed convergence-retraction nystagmus when looking at an optokinetic drum whose targets were being rotated downward. When the targets were moving upward, to the right, or to the left, the response was normal. In primary position, the patient had a 4 prism dioptre intermittent left hypotropia at distance and near, associated with 4˚of intorsion of the left eye using double Maddox rods. He was most comfortable with a 4 prism dioptre prism placed base up over the left spectacle lens, and a Fresnel prism of this strength and orientation was placed on the left lens of his glasses. He had no ptosis or lid retraction, and the results of slit lamp biomicroscopy, applanation tonometry, and ophthalmoscopy were normal.
Comment
The dorsal midbrain syndrome of Parinaud usually results from damage to premotor pathways for binocular upward gaze in the dorsal mesencephalon. 2 Depending on the extent of damage, the patient may have pursuit saccadic dissociation, with better upward gaze during pursuit than when attempting upward saccades, and some patients have improved upward gaze with the oculocephalic manoeuvre, indicating sparing of infranuclear pathways. The dorsal midbrain syndrome may be caused by extrinsic or intrinsic lesions, with hydrocephalus being a common aetiology in some series. 1 3 Depending on the nature and extent of damage as well as the length of time the condition has been present before the underlying disorder is treated, some patients improve, often substantially, whereas others do not. In general, patients whose underlying condition is treated successfully but who do not improve within a few weeks to months are thought to have no potential to improve; however, our patient's spontaneous improvement about 4K years after onset and treatment of the underlying condition indicates that some patients retain the potential to improve even after several years have passed. This information may be of value in counselling patients with the dorsal midbrain syndrome who ask if there is any chance of improvement when none has occurred after months to a few years.
Purification of triamcinolone acetonide suspension for intravitreal injection
In the article by García-Arumí and associates, 1 the authors reported the results of several techniques used for purification of triamcinolone acetonide suspension for intravitreal injection (two filter and two non-filter techniques). I very much appreciate that they finally recommended our method (centrifugation for 5 minutes at 3000 rpm with extraction of 0.9 ml of the supernatant and pellet resuspension with 0.9 ml of balanced salt solution, BSS) among those compared. 2 This could have been an interesting report but I want to raise some important issues mentioned in their paper. The source of the evaluated techniques was not clearly specified by the authors. Are they previously published techniques? Are they techniques developed entirely by García-Arumí et al? As far as I know, the centrifugation technique described by García-Arumí et al was first reported by Hernaez-Ortega in 2003 3 and it was first published by Hernaez-Ortega and myself in the 2004 July/August issue of Ophthalmic Surgery, Lasers & Imaging.
2 In fact, the term ''purification'' was first applied to removal of most of the vehicle from a commercially available triamcinolone acetonide suspension by us.
Parametric tests tend to be more powerful than non-parametric tests if their distributional assumptions are met. However, non-parametric methods require fewer MAILBOX assumptions, and they are generally robust against problems like outliers and non-constant variances. The authors tested statistical significance by the Kruskal-Wallis test, a non-parametric procedure that is a K-sample generalisation of the two sample rank sum test (also called the Mann-Whitney U test). It tests the null hypothesis of identical group medians, rather than means. With the data available in this report, the authors should have noticed that figures 1 and 2 show means and standard deviations; they should instead have shown group medians. Moreover, their results should have been expressed as medians. 4 It also remains unclear how many assays were performed. By looking at figures 1 and 2, it seems that three assays were done each time but somehow they were done in duplicate. This is important to show the real sample size that was used to compute the estimates.
The pellet resuspension with 0.9 ml of BSS in the centrifugation technique appeared in their final recommendation at the end of the paper. However, the authors stated in the methods section that the pellet was resuspended with 1 ml of BSS. This point needs to be explained.
I recommend that the authors clarify the above mentioned issues. I also suggest that they learn the golden rule of fair use of another author's protected material: take from someone else only what you wouldn't mind someone taking from you. 
PHEMA as a keratoprosthesis material
An aim to provide an optimised keratoprosthesis, with excellent biointegration, and all other properties meeting ideal requirements, is one we share with Mehta et al. 1 However, their paper includes some points that require clarification.
PHEMA (poly(2-hydroxyethyl methacrylate) is a non-toxic polymer of the toxic monomer HEMA, though cytotoxicity is still possible if non-reacted monomer has not been fully removed. The ''polyhydroxyethyl methacrylate'' the authors obtained for their study was not fully described, and may have been contact lens blanks, unlikely to have been processed for ''implantable quality.'' Whether the samples had been fully extracted was not stated, nor was the hydration of the samples when used for the study. Contact lens blanks are not designed for cell adhesion and the results of this study, with regard to PHEMA, are entirely predictable and have been previously reported.
The commercially available keratoprosthesis AlphaCor is made from a form of PHEMA, specifically modified for its intended purpose within the cornea. In particular, the AlphaCor OPTIC is made from a relatively low water content, but hydrated, microporous form, similar to the samples evaluated by the authors, specifically because it does not encourage cellular adhesion (epithelial coverage is not desired for this model, nor would adherent posterior cells and membranes be desirable).
In contradistinction, the biointegratable SKIRT region of AlphaCor is made from a macroporous form of PHEMA with a very high water content; this material, with its interconnecting channels, has been optimised to promote viable biocolonisation, which has been extensively described in the literature. Mehta et al do concede that cells ''may behave differently in colonising a 3-D porous keratoprosthesis skirt'': indeed they do. Further, very subtle modifications of the sponge structure significantly affect all aspects of biointegration.
Both early trial results, such as the preliminary cases cited by Mehta et al, and current results for over 250 AlphaCor devices, have been extensively presented and made available to all device users. Histology now available from AlphaCor devices explanted from human recipients confirms that the biointegration process in humans is similar to that previously shown in the animal model, and maintained in the long term. As expected, specific inflammatory processes can cause localised reversal of biointegration in areas of stromal melting. Certainly, porosity itself does not prevent melting processes, as is also seen in relation to hydroxyapatite keratoprostheses and orbital implants.
There is no argument that keratoprosthesis materials and design require ongoing revision and improvement. The authors' findings in relation to hydroxyapatite are interesting although, as they note, this rigid material has its own limitations. Novel approaches are undergoing early evaluation and may offer benefits. However, at present, in our view, AlphaCor is a device worthy of consideration for those in whom a donor graft would fail.
